ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Clinical Neurophysiology

Top Clinical Neurophysiology Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ITZHAK HAIMOVIC M.D.

Clinical Neurophysiology

5,346

$1.1M

942
821 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 28%

$205
Average prescription price

Avg: $187

ANDREI CARASCA MD

Clinical Neurophysiology

1,610

$118K

215
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 28%

$73
Average prescription price

Avg: $187

DOUGLAS LABAR MD

Clinical Neurophysiology

1,362

$381K

99
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 28%

$280
Average prescription price

Avg: $187

RICHARD COWAN MD

Clinical Neurophysiology

817

$102K

46
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 28%

$124
Average prescription price

Avg: $187

ROBERT GOLD M.D.

Clinical Neurophysiology

696

$57.6K

24
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 28%

$83
Average prescription price

Avg: $187

CRISTINA DRAFTA MD

Clinical Neurophysiology

689

$169K

137
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 28%

$245
Average prescription price

Avg: $187

KIRIL KIPROVSKI MD

Clinical Neurophysiology

607

$161K

103
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 28%

$265
Average prescription price

Avg: $187

ALCIBIADES RODRIGUEZ MD

Clinical Neurophysiology

509

$145K

98
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 28%

$285
Average prescription price

Avg: $187

SAIT ASHINA MD

Clinical Neurophysiology

488

$74.7K

98
39 are 65+

67%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$153
Average prescription price

Avg: $187

HIND KETTANI M.D

Clinical Neurophysiology

468

$167K

36
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 28%

$357
Average prescription price

Avg: $187

AMIT KHANEJA

Clinical Neurophysiology

452

$38.5K

116
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 28%

$85
Average prescription price

Avg: $187

VENKAT RAMANI MD

Clinical Neurophysiology

349

$52.8K

36
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 28%

$151
Average prescription price

Avg: $187

HAZEM ALI M.D.

Clinical Neurophysiology

231

$6,300

48
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 28%

$27
Average prescription price

Avg: $187

MOHINI GURME M.D.

Clinical Neurophysiology

223

$19.1K

33
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 28%

$86
Average prescription price

Avg: $187

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank